The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

Management believes the Performance TV market is shifting from early adopters to the mainstream, prompting a strategic expansion of the leadership team with industry veterans from NBCUniversal and performance marketing backgrounds.

Revenue growth of 14% year-over-year was driven by the U.S. business, specifically the adoption of AtriClip Flex Mini and Cryosphere Max Pro devices, which contributed roughly 70% of pain management sales.

The company is accelerating its BOX NOAF clinical trial, with enrollment tracking nearly one year ahead of the original plan due to high surgeon engagement regarding postoperative AFib complications.

A significant competitive advantage is being realized through the AtriClip Flex Mini, which is driving market share gains by attracting surgeons previously using competitive devices due to its smaller form factor.

Management attributes gross margin expansion of 246 basis points to a favorable product mix and the strategic spin-out of the Maximum Effort creative unit, which reduced creative COGS.

The company maintains a 'purpose-built' approach for the SMB market, integrating AI-driven targeting and programmatic bidding engines specifically designed for businesses with smaller target pools and no existing TV creative.

Full-year 2026 guidance assumes an acceleration in the second half, supported by a fiscal year revenue target of $347 million to $357 million, representing 24% growth at the midpoint.

The company expects to launch AtriClip Flex Mini and Pro Mini in Europe later this year following recent CE Mark approval under EU MDR.

Management anticipates completing enrollment for the 960-patient BOX NOAF randomized controlled trial by the end of 2026, significantly ahead of the initial timeline.

Future growth is expected to be supported by the transition of QuickFrame AI 3.0 from beta to full production, aimed at reducing the time-to-live for new advertisers.

The company is preparing to release a new AI-driven media planning tool to further differentiate its platform from enterprise-focused competitors.

The minimally invasive ablation (MIS) franchise continues to face headwinds, with U.S. sales declining approximately 25% year-over-year.

International growth was tempered by ongoing uncertainty in the U.K. market and lower distributor sales in Asia.

The spin-out of Maximum Effort and a change in hosting providers were cited as key structural drivers for reaching the 81% gross margin level this quarter.

Management flagged a 'throttling' strategy for onboarding small business customers to ensure the cost of acquisition remains sustainable and profitable.

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.

The hires of Garland Hill and Peter Blacker are intended to capture the 'mainstream' market as Performance TV moves beyond early adopters.

Management is leveraging their networks and experience in streaming (Peacock/NBCU) to ensure MNTN Inc. can reach consumers across all emerging live sports and tentpole events.

Version 3.0 is considered 'full production' because it can now generate professional-quality commercials rather than just video clips.

The tool is primarily an enabler for the core business rather than a standalone revenue stream, significantly reducing 'go-live' times for SMBs who lack internal creative teams.

Management argues that enterprise platforms cannot easily move down-market because SMBs require different sales motions, pinpoint targeting for small pools, and built-in creative solutions.

MNTN Inc. claims a '100% win rate' in head-to-head performance trials because their ad stack is purpose-built for driving direct outcomes rather than brand awareness.

Management reports 'nearly zero impact' from macro concerns, noting that SMBs are often more determined to grow during difficult environments.

Spending on the platform is dictated strictly by Return on Ad Spend (ROAS) metrics rather than discretionary budget cycles.

One stock. Nvidia-level potential. 30M+ investors trust Moby to find it first. Get the pick. Tap here.